Visit us at

The ATA 2023 Annual Meeting – Booth #208
The AAO-HNSF 2023 Annual Meeting & OTO Experience – Booth #2217
The ASCP Annual Meeting – Booth #116

The Majority of Non-­Diagnostic (Insufficient) Thyroid Nodule Cytology Samples Can Effectively Undergo Molecular (Combined Mutational and microRNA Classifier) Analysis Using a Needle Aspiration Approach

2016 ATA Denver, CO
  • Non-­diagnostic cytology (NDC) (Bethesda I) occurs in 5%­‐20% of thyroid nodule fine needle aspirates (FNAs), often resulting in repeat FNAs and increasing healthcare costs
  • The NDC topic tends to be overlooked but is potentially addressable by molecular analysis

Patient management decisions are based on the independent medical judgment of the physician and molecular test results should be taken into consideration in conjunction with all relevant imaging, clinical findings, patient and family history, as well as patient preference.